Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. That’s according to two internists who work closely with hospitalized patients who take GLP-1s.

Hospital 63

Hospital Management Diabetes Patients 63

GeriPal

OCTOBER 17, 2024

We talk about what is heart failure, particularly HFpEF, how we treat it (including the use of sodium–glucose cotransporter-2 inhibitors (SGLT2’s), and how we should apply guidelines to individual patients, especially those with multimorbidity who are taking a lot of other medications. But we’re not perfect individuals.

Primary Care 113

Primary Care Patient-Centered IT Patients 113

GeriPal

AUGUST 1, 2024

So if you already have a condition, you might be able to prevent events. But at any age, like, as Emily said, it is so important to pay attention to nutrition and healthy eating because it’s not just about, oh, chronic disease prevention or even treatment and management. And you can work at different levels of prevention.

IT 116

IT Diabetes Chronic Disease Patient-Centered 116